Cargando…
Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
In-stent restenosis (ISR) is one of the main complications in patients undergoing percutaneous coronary angioplasty, and microRNAs participate in the contractile-to-synthetic phenotypic switch of vascular smooth muscle cells, a hallmark of restenosis development. MicroRNAs (miRNAs) can be released i...
Autores principales: | Saavedra, Nicolás, Rojas, Gabriel, Herrera, Jesús, Rebolledo, Camilo, Ruedlinger, Jenny, Bustos, Luis, Bobadilla, Braulio, Pérez, Luis, Saavedra, Kathleen, Zambrano, Tomás, Lanas, Fernando, Salazar, Luis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519453/ https://www.ncbi.nlm.nih.gov/pubmed/33015157 http://dx.doi.org/10.1155/2020/2509039 |
Ejemplares similares
-
CYP2C19(⁎)2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls
por: Ruedlinger, Jenny, et al.
Publicado: (2017) -
Differential Expression of miRNA-223 in Coronary In-Stent Restenosis
por: Ganjali, Shiva, et al.
Publicado: (2022) -
Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation
por: McDonald, Robert A., et al.
Publicado: (2015) -
Integrative Analysis of miRNA-mRNA and miRNA-miRNA Interactions
por: Guo, Li, et al.
Publicado: (2014) -
Diagnostic value of elevated serum miRNA-143 levels in sepsis
por: Han, Yu, et al.
Publicado: (2016)